Do opioids induce hyperalgesia in humans? An evidence-based structured review

Pain Medicine

Volumn 10, Issue 5, 2009, Pages 829-839

  Fishbain, David A ^a,b,c   Cole, Brandly ^c   Lewis, John E ^a   Gao, Jinrun ^d   Rosomoff, R Steele ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c The Rosomoff Comprehensive Pain Center at Douglas Gardens   (United States)

^d State Farm Insurance   (United States)

Author keywords

Allodynia; Evidence based structured review; Humans; Hyperalgesia; Opioid induced hyperalgesia; Opioids; Pain

Indexed keywords

OPIATE DERIVATIVE;

ALLODYNIA; CHRONIC PAIN; DRUG DETOXIFICATION; DRUG DOSE REDUCTION; DRUG TOLERANCE; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; HYPERALGESIA; OPIATE ADDICTION; PAIN THRESHOLD; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; QUALITY CONTROL; REVIEW;

ANALGESICS, OPIOID; ANIMALS; CHRONIC DISEASE; DRUG TOLERANCE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERALGESIA; OPIOID-RELATED DISORDERS; PAIN THRESHOLD; RESEARCH DESIGN;

EID: 68349127240     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00653.x     Document Type: Review

References (82)

1. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994;14:2301-12.
2. Mao J, Sung B, Ji RR, Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: Implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002;22:8312-23.
3. Mao J, Sung B, Ji RR, Lim G. Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002; 22: 7650-61.
4. Celerier E, Rivat C, Jun Y, et al. Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2000;92:465-72.
5. Laulin JP, Maurette P, Corcuff JB, et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002; 94: 1263-9.
6. Celerier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. J Neurosci 2001;21:4074-80.
7. Vanderah TW, Ossipov MH, Lai J, Malan TP Jr, Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: Descending facilitation and spinal dynorphin. Pain 2001;92:5-9.
8. Sakurada T, Komatsu T, Sakurada S. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 2005;26:801-9.
9. Li X, Angst MS, Clark JD. Opioid-induced hyperalgesia and incisional pain. Anesth Analg 2001;93(1):204-9.
10. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002;100:213-17.
11. Mao J, Mayer DJ. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann N Y Acad Sci 2001;933:175-84.
12. Vanderah TW, Ossipov MH, Lai J, Malan TP Jr, Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: Descending facilitation and spinal dynorphin. Pain 2001;92:5-9.
13. Angst MS, Clark JD. Opioid-induced hyperalgesia. Anesthesiology 2006;104(3):570-87.
14. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Steele-Rosomoff R. What percentage of chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008;9(4):444-59.
15. Institute of Medicine Committee to Advise Public Health Service on Clinical Practice. Clinical Practice Guidelines Directions for a New Program. Washington, DC: National Academy Press; 1990.
16. Simonnet G, Rivat C. Opioid-induced hyperalgesia: Abnormal or normal pain? Neuroreport 2003;14(1):1-7.
17. King T, Ossipov MH, Vanderah TW, Porreca F, Lai J. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 2005;14:194-205.
18. Koppert W. Opioid-induced hyperalgesia. Pathophysiology and clinical relevance. Anaesthesist 2004;53(5):455-66.
19. Ossipov MH, Lai J, King T, et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004;61:126-48.
20. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: Relationship to opioid antinociceptive tolerance. Life Sci 2003;73:783-800.
21. White JM. Pleasure into pain: The consequences of long-term opioid use. Addict Behav 2004;29:1311-24.
22. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000;19(1):53-62.
23. Martin JE, Inglis J. Pain tolerance and narcotic addiction. Bri J Soc Clin Psychol 1965;4:224-9.
24. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982;33:335-41.
25. Koppert W, Ihmsen H, Korber N, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 2005;118(1-2):15-22.
26. De Leon-Casasola O, Myers DP, Donaparthi S, et al. A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naïve patients. Anesth Analg 1993;76:302-7.
27. Seymour RA, Rawlins MD, Rowell FJ. Dihydrocodeine-induced hyperalgesia in postoperative dental pain. Lancet 1982;8287 (Uune 26): 425-6.
28. Edwards JE, McQuay HJ, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2007;3:19-25.
29. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: A preliminary study. J Pain 2003;4(9):511-19.
30. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001;90(1-2):91-6.
31. Pud D, Cohen D, Lawental E, Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 2006;82(3):218-23.
32. Eisenberg E, Cohen D, Lawental E, Pud D. Personality traits and sensitivity to pain in male chronic opioid addicts. J Opioid Manage 2007;3(4):225-30.
33. Athanasos P, Smith CS, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain 2006;120(3):267-75.
34. Schall U, Katta T, Pries E, Klöppel A, Gastpar M. Pain perception of intravenous heroin users on maintenance therapy with levomethadone. Pharmacopsychiatry 1996;29:176-9.
35. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Depend 2001;63:139-46.
36. Compton P, Charuvastra C, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 2000;20(4):237-45.
37. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. J Pain Symptom Manage 1994;9(7):462-73.
38. Ho A, Dole VP. Pain perception in drug-free and methadone-maintained human ex-addicts (40689). Proc Soc Exp Biol Med 1979;162:392-5.
39. Mercadante S, Ferrera P, Villari P, Arcuri E. Hyperalgesia: An emerging iatrogenic syndrome. J Pain Symptom Manage 2003;26(2):769-75.
40. Parisod E, Siddall PJ, Viney M, McClelland JM, Cousins MJ. Allodynia after acute intrathecal morphine administration in a patient with neuropathic pain after spinal cord injury. Anesth Analg 2003;97:183-6.
41. Chung KS, Carson S, Glassman D, Vadivelu N. Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia. Conn Med 2004;68(9):547-9.
42. Bruera E, Pereira J. Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain. Pain 1997;69(1-2):199-201.
43. Sjögren P, Thunedborg LP, Christrup L, Hansen SH, Franks J. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories. Acta Anaesth Scand 1998;42(9):1070-5.
44. Lawlor P, Walker P, Bruera E, Mitchell S. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage 1997;13(6):356-61.
45. Sjögren P, Jensen NH, Jensen TS. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994;59:313-6.
46. Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hosp Palliat Med 2005;22(4):291-4.
47. Heger S, Maier C, Otter K, Helwig U, Suttorp M. Morphine induced allodynia in a child with brain tumour. BMJ 1999;319:627-9.
48. Devulder J. Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain. J Neurosurg Anesthesiol 1997;9(2):146-8.
49. Stillman MJ, Moulin DE, Foley KM. Paradoxical pain following high-dose spinal morphine. Pain 1987;(suppl 4):S389.
50. DeConno F, Caraceni A, Martini C, et al. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 1991;47:337-9.
51. Ali MK. Hyperalgesic response in a patient receiving high concentrations of spinal morphine. Anesthesiology 1986;65(4):449.
52. Sjögren P, Jonsson T, Jensen NH, Drenck NE, Jensen TS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993;55:93-7.
53. Axelrod DJ, Reville B. Using methadone to treat opioid-induced hyperalgesia and refractory pain. J Opioid Manag 2007;3(2):113-14.
54. Wilson GR, Reisfield GM. Morphine hyperalgesia: A case report. J Hosp Palliat Care 2003;20(6):459-61.
55. Brodner RA, Taub A. Chronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease; clinical syndrome and treatment. Mt Sinai J Med 1978;45(2):233-7.
56. Taylor CB, Zlutnick SI, Corley MJ. The effects of detoxification, relaxation, and brief supportive therapy on chronic pain. Pain 1980;8:319-29.
57. Miller NS, Swiney T, Barkin RL. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. Am J Ther 2006;13(5):436-44.
58. Townsend C, Hooten W, Bruce B, et al. Pain rehabilitation with opioid withdrawal; longitudinal study of treatment outcomes for chronic noncancer pain. J Pain 2007; 8 (suppl 1): S41.
59. Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag 2006;2(5):277-82.
60. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 2006;7(1):43-8.
61. Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 2005;60(3):311-18.
62. Luginbühl M, Gerber A, Schnider TW, et al. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 2003;96:726-32.
63. Holtman J, Johnson J, Kelly T, Wala E. Opioid-induced abnormal pain sensitivity. J Pain 2007; 8 (4) (suppl 1): S16.
64. Vinik HR, Kisson I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998;86:1307-11.
65. Gustorff B, Nahlik G, Hoerauf KH. The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg 2002;94:1223-8.
66. Lipman JJ, Blumenkopf B. Comparison of subjective and objective analgesic effects of intravenous and intrathecal morphine in chronic pain patients by heat beam dolorimetry. Pain 1989;39:249-56.
67. Andrews HL. The effects of opiates on the pain threshold in post-addicts. J Clin Invest 1943;22(4):511-16.
68. Peterson KL, Jones B, Segredo V, Dahl JB, Rowbotham MC. Effect of remifentanil on pain and secondary hyperalgesia associated with the Heat-capsaicin sensitization model in healthy volunteers. Anesthesiology 2001;94(1):15-20.
69. Koppert W, Sitti R, Scheuber K, et al. Differential modulation of remifentanil-induced analgesia and post infusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99:152-9.
70. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106: 49-57.
71. Koppert W, Angst M, Alsheimer M, et al. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain 2003;106:91-9.
72. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-15.
73. Cooper DW, Lindsay SL, Ryall DM, et al. Does intrathecal fentanyl produce acute cross-tolerance to I.V. morphine? Br J Anaesth 1997;78:311-13.
74. Chia YY, Liu K, Wang JJ, MC K, Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anesth 1999;46(9):872-7.
75. Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance. Intraoperative remifentanil increases operative pain and morphine requirement. Anesthesiology 2000;93:409-17.
76. Cortinez LI, Brandes V, Muñoz HR, Guerrero ME, Mur M. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001;87(6):866-9.
77. Schraag S, Checketts MR, Kenny G. Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain. Anesth Analg 1999;89:753-7.
78. Hoogendoorn WE, van Poppel MN, Bongers PM, Koes BW, Bouter LM. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 2000;25:2114-25.
79. Verhagen AP, de Vet HC, de Bie RA, et al. Systematic reviews on the basis of methodological criteria. Physiotherapy 1997;83:284-9.
80. Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: A systematic review. Pain 1998;77:1-13.
81. O'Neille S, Manniche C, Graven-Nielsen T, Arendt-Nielsen L. Generalized deep-tissue hyperalgesia in patients with chronic low back pain. Eur J Pain 2007;11(4):415-20.
82. Wong F, Currie T, King C, Mauderli A. Hypersensitivity to cutaneous thermal nociceptive stimuli in myofascial pain and fibromyalgia symptoms. Am Pain Society 27th Annual Scientific Meeting May 8-10, 2008.